Gary Guthart compensation by year
INTUITIVE SURGICAL Summary Compensation Table · all 6 fiscal years held| Component | FY2019 | FY2020 | FY2021 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Salary | $789,750 | $821,475 | $846,119 | $955,000 | $1,006,250 | $866,250 |
| Bonus | $0 | — | — | — | — | $0 |
| Stock awards | $2,742,500 | $2,752,030 | $2,976,672 | $7,385,307 | $15,559,188 | $15,954,662 |
| Option awards | $2,123,911 | $2,468,357 | $2,858,652 | $2,442,064 | — | $0 |
| Non-equity incentive | $812,713 | — | $1,376,466 | $1,610,743 | $1,628,994 | $886,156 |
| Pension and deferred compensation | $0 | — | — | — | — | $0 |
| All other | $1,500 | $1,500 | $1,500 | $56,267 | $2,000 | $387,869 |
| Total | $6,470,374 | $6,043,362 | $8,059,409 | $12,449,381 | $18,196,432 | $18,094,937 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: INTUITIVE SURGICAL INC DEF 14A filed March 13, 2026, accession 0001035267-26-000023, and prior-year filings. Open the filing on EDGAR.
Equity holdings
unvested awards at FY2025 year-end| Type | Unvested units | Value at year-end | Exercise price |
|---|---|---|---|
| RSU | 17,556 | $9,943,016 | — |
| RSU | 17,164 | $9,721,003 | — |
| PSU | 16,533 | $9,363,630 | — |
| RSU | 14,880 | $8,427,437 | — |
| RSU | 13,732 | $7,777,256 | — |
| PSU | 8,778 | $4,971,508 | — |
| RSU | 8,267 | $4,682,098 | — |
| RSU | 5,266 | $2,982,452 | — |
| RSU | 2,506 | $1,419,298 | — |
| Option | 627 | — | $208.90 |
| Option | 627 | — | $290.33 |
| Option | 4,609 | — | $229.39 |
Per the Outstanding Equity Awards at Fiscal Year-End table in INTUITIVE SURGICAL INC's FY2025 proxy; value at the fiscal year-end close, as the company printed it. The 12 largest of 13 award rows shown.
Insider transactions since the last proxy
2 Form 4 lines since the FY2025 proxy (filed March 13, 2026)current to 2026-09-24 · updated nightly
| Date | Transaction | Plan | Shares | Price | Held after |
|---|---|---|---|---|---|
| 2026-08-11 | Sale | 10b5-1 | 10,000 | $400.00 | 1,245,679 |
| 2026-04-30 | Grant or award derivative | — | 554 | $0.00 | 554 |
The 2 most recent of 2 lines, each as reported on the Form 4. "10b5-1" marks a trade the filing reports under a pre-arranged trading plan. View every Form 4 filing on EDGAR →
INTUITIVE SURGICAL’s named executive officers, FY2025
as the company reported each| Named executive officer | Role | FY2025 total |
|---|---|---|
| David Rosa | Chief Executive Officer | $20,997,480 |
| Gary Guthart · this page | Executive Chair of the Board of Directors | $18,094,937 |
| Jamie Samath | Executive Vice President, Chief Financial Officer and Enterprise Technology Leader | $8,396,045 |
| Henry Charlton | Executive Vice President and Chief Commercial and Marketing Officer | $6,240,703 |
| Gary Loeb | Executive Vice President and Chief Legal and Compliance Officer | $5,590,139 |
| Mark Brosius | Senior Vice President and Chief Manufacturing and Supply Chain Officer | $5,543,260 |
The full INTUITIVE SURGICAL compensation record
free company briefThis page is one person within INTUITIVE SURGICAL's record. The company brief lists every named executive, each linking to their own page.
Compensation, the day it’s disclosed
The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them. Or order INTUITIVE SURGICAL's full Executive Compensation Report with peer benchmarking.
How this record is built
Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are INTUITIVE SURGICAL's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.
Velarion Pro: every company page, peer tools and exports, one seat